These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31756512)

  • 1. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
    Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
    Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates.
    Adams T; Ennuson NAA; Quashie NB; Futagbi G; Matrevi S; Hagan OCK; Abuaku B; Koram KA; Duah NO
    Parasit Vectors; 2018 Mar; 11(1):175. PubMed ID: 29530100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
    She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
    BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
    Chebore W; Zhou Z; Westercamp N; Otieno K; Shi YP; Sergent SB; Rondini KA; Svigel SS; Guyah B; Udhayakumar V; Halsey ES; Samuels AM; Kariuki S
    Malar J; 2020 Aug; 19(1):291. PubMed ID: 32795367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.
    Cheng W; Song X; Tan H; Wu K; Li J
    Malar J; 2021 May; 20(1):209. PubMed ID: 33933099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
    Ocan M; Ashaba FK; Mwesigwa S; Edgar K; Kamya MR; Nsobya SL
    PLoS One; 2022; 17(5):e0268095. PubMed ID: 35511795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
    Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
    Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.
    Bwire GM; Ngasala B; Mikomangwa WP; Kilonzi M; Kamuhabwa AAR
    Sci Rep; 2020 Feb; 10(1):3500. PubMed ID: 32103124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
    Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
    Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
    Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
    Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
    Maniga JN; Samuel M; John O; Rael M; Muchiri JN; Bwogo P; Martin O; Sankarapandian V; Wilberforce M; Albert O; Onkoba SK; Adebayo IA; Adeyemo RO; Akinola SA
    Malar J; 2023 Mar; 22(1):87. PubMed ID: 36894982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
    He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
    PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
    Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
    Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.